Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
| Cat. No. | Especies | Descripción del producto | Estructura | Pureza | Característica |
|---|---|---|---|---|---|
| CA1-H81E3 | Human | Biotinylated Human Catenin beta-1 Protein, His,Avitag™ (MALS verified) |  |
|
|
| CA1-H51H3 | Human | Human Catenin beta-1 Protein, His Tag (MALS verified) |  |
|
The purity of Biotinylated Human Catenin beta-1, His,Avitag (Cat. No. CA1-H81E3) is more than 95% and the molecular weight of this protein is around 62-72 kDa verified by SEC-MALS.
The purity of Human Catenin beta-1 Protein, His Tag (Cat. No. CA1-H51H3) is more than 90% and the molecular weight of this protein is around 55-70 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| CEQ-508 | CEQ-508 | Phase 2 Clinical | Marina Biotech | Adenomatous Polyposis Coli | Details |
| Foscenvivint | PRI-724; ICG-001; OP-724 | Phase 2 Clinical | University Of Southern California, Prism Pharma Co Ltd | Leukemia, Myelogenous, Chronic; Liver Cirrhosis, Biliary; Solid tumours; Pancreatic Neoplasms; Liver Cirrhosis; Hepatitis B; Hepatitis C; Colorectal Neoplasms; Leukemia, Myeloid, Acute | Details |
| Tegatrabetan | BC-2059; APL-121 | Phase 2 Clinical | Allergan Plc | Sarcoma, Ewing; Fibroma; Melanoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Endometrial Neoplasms; Lymphoma, Non-Hodgkin; Lung Neoplasms; Colorectal Neoplasms; Neuroblastoma; Solid tumours; Osteosarcoma; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Pancreatic Neoplasms; Carcinoma, Ovarian Epithelial; Wilms Tumor; Hepatoblastoma; Lymphoma, B-Cell; Fibromatosis, Aggressive; Leukemia | Details |
| CWP-232291 | CWP-291; CWP-232291 | Phase 2 Clinical | Jw Pharmaceutical Corp | Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Multiple Myeloma; Primary Myelofibrosis; Leukemia, Myeloid, Acute | Details |
| FOG-001 | FOG-001 | Phase 2 Clinical | Fog Pharmaceuticals Inc | Adenomatous Polyposis Coli; Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Neoplasms; Digestive System Neoplasms; Colorectal Neoplasms; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
| E-7386 | E-7386 | Phase 2 Clinical | Prism Pharma Co Ltd, Eisai Co Ltd | Liver Neoplasms; Solid tumours; Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Melanoma; Carcinoma, Hepatocellular; Gastrointestinal Neoplasms | Details |
| ALN-BCAT | ALN-BCAT | Phase 1 Clinical | Alnylam Pharmaceuticals Inc | Carcinoma, Hepatocellular | Details |
| ST-316 | ST-316 | Phase 1 Clinical | Sapience Therapeutics Inc | Hematologic Neoplasms; Solid tumours; Ovarian Neoplasms; Colonic Neoplasms; Pancreatic Neoplasms; Skin Neoplasms; Triple Negative Breast Neoplasms; Sarcoma, Synovial; Cholangiocarcinoma; Metastatic breast cancer; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular | Details |
| VTX-003 | Neoplasms | Details | |||
| CEQ-508 | CEQ-508 | Phase 2 Clinical | Marina Biotech | Adenomatous Polyposis Coli | Details |
| Foscenvivint | PRI-724; ICG-001; OP-724 | Phase 2 Clinical | University Of Southern California, Prism Pharma Co Ltd | Leukemia, Myelogenous, Chronic; Liver Cirrhosis, Biliary; Solid tumours; Pancreatic Neoplasms; Liver Cirrhosis; Hepatitis B; Hepatitis C; Colorectal Neoplasms; Leukemia, Myeloid, Acute | Details |
| Tegatrabetan | BC-2059; APL-121 | Phase 2 Clinical | Allergan Plc | Sarcoma, Ewing; Fibroma; Melanoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Endometrial Neoplasms; Lymphoma, Non-Hodgkin; Lung Neoplasms; Colorectal Neoplasms; Neuroblastoma; Solid tumours; Osteosarcoma; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Pancreatic Neoplasms; Carcinoma, Ovarian Epithelial; Wilms Tumor; Hepatoblastoma; Lymphoma, B-Cell; Fibromatosis, Aggressive; Leukemia | Details |
| CWP-232291 | CWP-291; CWP-232291 | Phase 2 Clinical | Jw Pharmaceutical Corp | Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Multiple Myeloma; Primary Myelofibrosis; Leukemia, Myeloid, Acute | Details |
| FOG-001 | FOG-001 | Phase 2 Clinical | Fog Pharmaceuticals Inc | Adenomatous Polyposis Coli; Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Neoplasms; Digestive System Neoplasms; Colorectal Neoplasms; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis | Details |
| E-7386 | E-7386 | Phase 2 Clinical | Prism Pharma Co Ltd, Eisai Co Ltd | Liver Neoplasms; Solid tumours; Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Melanoma; Carcinoma, Hepatocellular; Gastrointestinal Neoplasms | Details |
| ALN-BCAT | ALN-BCAT | Phase 1 Clinical | Alnylam Pharmaceuticals Inc | Carcinoma, Hepatocellular | Details |
| ST-316 | ST-316 | Phase 1 Clinical | Sapience Therapeutics Inc | Hematologic Neoplasms; Solid tumours; Ovarian Neoplasms; Colonic Neoplasms; Pancreatic Neoplasms; Skin Neoplasms; Triple Negative Breast Neoplasms; Sarcoma, Synovial; Cholangiocarcinoma; Metastatic breast cancer; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular | Details |
| VTX-003 | Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z
